1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction

Chemico-Biological Interactions

Volumn 196, Issue 1-2, 2012, Pages 39-49

  Park, Su Young ^a   Ku, Sae Kwang ^b   Lee, Eung Seok ^a   Kim, Jung Ae ^a  

^a Yeungnam University   (South Korea)

^b Daegu Hany University   (South Korea)

Author keywords

Angiogenesis; IBD; IL 8; NF B; Phenylpropenone

Indexed keywords

1,3 DIPHENYLPROPENONE; ALKYL PHENYL KETONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MESALAZINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TRANSCRIPTION FACTOR RELA; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL NUCLEUS; CHICK; CHORIOALLANTOIS; COLITIS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INTESTINE EPITHELIUM CELL; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; STOMACH MUCOSA INJURY; WEIGHT REDUCTION;

ANIMALS; CELL ADHESION; CELL SURVIVAL; CHALCONES; COLITIS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRINITROBENZENESULFONIC ACID; U937 CELLS;

RATTUS;

EID: 84862824392     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.02.002     Document Type: Article

References (54)

1. D.K. Podolsky Inflammatory bowel disease N. Engl. J. Med. 347 2002 417 429 (Pubitemid 34851835)
2. C.O. Elson, Y. Cong, V.J. McCracken, R.A. Dimmitt, R.G. Lorenz, and C.T. Weaver Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota Immunol. Rev. 206 2005 260 276 (Pubitemid 41105175)
3. T. Kucharzik, C. Maaser, A. Lugering, M. Kagnoff, L. Mayer, S. Targan, and W. Domschke Recent understanding of IBD pathogenesis: implications for future therapies Inflamm. Bowel Dis. 12 2006 1068 1083
4. C.C. Schuerer-Maly, L. Eckmann, M.F. Kagnoff, M.T. Falco, and F.E. Maly Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide Immunology 81 1994 85 91 (Pubitemid 24249837)
5. L. Eckmann, H.C. Jung, C. Schurer-Maly, A. Panja, E. Morzycka-Wroblewska, and M.F. Kagnoff Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8 Gastroenterology 105 1993 1689 1697 (Pubitemid 24002784)
6. H.C. Jung, L. Eckmann, S.K. Yang, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M.F. Kagnoff A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion J. Clin. Invest. 95 1995 55 65
7. S. Nikolaus, J. Bauditz, P. Gionchetti, C. Witt, H. Lochs, and S. Schreiber Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation Gut 42 1998 470 476 (Pubitemid 28186561)
8. F. Pallone, and G. Monteleone Regulatory cytokines in inflammatory bowel disease Aliment. Pharmacol. Ther. 10 Suppl. 2 1996 75 79 discussion 80 (Pubitemid 26341299)
9. M. Boirivant, M. Marini, G. Di Felice, A.M. Pronio, C. Montesani, R. Tersigni, and W. Strober Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis Gastroenterology 116 1999 557 565 (Pubitemid 29106763)
10. M.S. Malo, S. Biswas, M.A. Abedrapo, L. Yeh, A. Chen, and R.A. Hodin The pro-inflammatory cytokines, IL-1beta and TNF-alpha, inhibit intestinal alkaline phosphatase gene expression DNA Cell Biol. 25 2006 684 695 (Pubitemid 46052614)
11. J. Heidemann, H. Ogawa, M.B. Dwinell, P. Rafiee, C. Maaser, H.R. Gockel, M.F. Otterson, D.M. Ota, N. Lugering, W. Domschke, and D.G. Binion Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 J. Biol. Chem. 278 2003 8508 8515 (Pubitemid 36800603)
12. A. Li, S. Dubey, M.L. Varney, B.J. Dave, and R.K. Singh IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis J. Immunol. 170 2003 3369 3376 (Pubitemid 36302216)
13. D. Thapa, J.S. Lee, S.Y. Park, Y.H. Bae, S.K. Bae, J.B. Kwon, K.J. Kim, M.K. Kwak, Y.J. Park, H.G. Choi, and J.A. Kim Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-kappaB-dependent manner J. Pharmacol. Exp. Ther. 327 2008 353 364
14. Y. Mahe, N. Mukaida, K. Kuno, M. Akiyama, N. Ikeda, K. Matsushima, and S. Murakami Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements J. Biol. Chem. 266 1991 13759 13763 (Pubitemid 21907416)
15. C. Stevens, G. Walz, C. Singaram, M.L. Lipman, B. Zanker, A. Muggia, D. Antonioli, M.A. Peppercorn, and T.B. Strom Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease Dig. Dis. Sci. 37 1992 818 826
16. Y. Umehara, M. Kudo, R. Nakaoka, T. Kawasaki, and M. Shiomi Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis Hepatogastroenterology 53 2006 879 882 (Pubitemid 44851220)
17. J.M. Reimund, C. Wittersheim, S. Dumont, C.D. Muller, R. Baumann, P. Poindron, and B. Duclos Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease J. Clin. Immunol. 16 1996 144 150 (Pubitemid 26166392)
18. Y. Suzuki, H. Saito, J. Kasanuki, T. Kishimoto, Y. Tamura, and S. Yoshida Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease Life Sci. 47 1990 2193 2197
19. S. Grivennikov, E. Karin, J. Terzic, D. Mucida, G.Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15 2009 103 113
20. R. Daig, T. Andus, E. Aschenbrenner, W. Falk, J. Scholmerich, and V. Gross Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease Gut 38 1996 216 222
21. L. Mazzucchelli, C. Hauser, K. Zgraggen, H. Wagner, M. Hess, J.A. Laissue, and C. Mueller Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation Am. J. Pathol. 144 1994 997 1007 (Pubitemid 24160640)
22. T. Yoshimura, K. Matsushima, S. Tanaka, E.A. Robinson, E. Appella, J.J. Oppenheim, and E.J. Leonard Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines Proc. Natl. Acad. Sci. USA 84 1987 9233 9237
23. A. Walz, P. Peveri, H. Aschauer, and M. Baggiolini Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes Biochem. Biophys. Res. Commun. 149 1987 755 761 (Pubitemid 18023044)
24. S. Subramanian, J.M. Rhodes, C.A. Hart, B. Tam, C.L. Roberts, S.L. Smith, J.E. Corkill, C. Winstanley, M. Virji, and B.J. Campbell Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine Inflamm. Bowel Dis. 14 2008 162 175 (Pubitemid 351288037)
25. P. Thapa, R. Karki, A. Basnet, U. Thapa, H. Choi, Y. Na, Y. Jahng, C.S. Lee, Y. Kwon, and E.S. Lee 2,6-Dithienyl-4-arylpyridines: synthesis, topoisomerase I and II inhibition and structure-activity relationship Bulletin Korean Chem. Society 29 2008 1605 1608
26. M. Baggiolini, B. Dewald, and B. Moser Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines Adv. Immunol. 55 1994 97 179
27. K.J. Laing, and C.J. Secombes Chemokines Dev. Comp. Immunol. 28 2004 443 460 (Pubitemid 38177447)
28. N. Mukaida, S. Okamoto, Y. Ishikawa, and K. Matsushima Molecular mechanism of interleukin-8 gene expression J. Leukoc. Biol. 56 1994 554 558 (Pubitemid 24348811)
29. S.K. Manna, and G.T. Ramesh Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway J. Biol. Chem. 280 2005 7010 7021 (Pubitemid 40341257)
30. G. Rogler, K. Brand, D. Vogl, S. Page, R. Hofmeister, T. Andus, R. Knuechel, P.A. Baeuerle, J. Scholmerich, and V. Gross Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa Gastroenterology 115 1998 357 369 (Pubitemid 28363428)
31. M.F. Neurath, S. Pettersson, K.H. Meyer zum Buschenfelde, and W. Strober Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice Nat. Med. 2 1996 998 1004 (Pubitemid 26306838)
32. H.T. Gan, Y.Q. Chen, and Q. Ouyang Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis J. Gastroenterol. Hepatol. 20 2005 1016 1024 (Pubitemid 40961223)
33. C. Wahl, S. Liptay, G. Adler, and R.M. Schmid Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B J. Clin. Invest. 101 1998 1163 1174 (Pubitemid 28125296)
34. C.K. Weber, S. Liptay, T. Wirth, G. Adler, and R.M. Schmid Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta Gastroenterology 119 2000 1209 1218
35. E.S. Lee, B.C. Park, S.H. Paek, Y.S. Lee, A. Basnet, D.Q. Jin, H.G. Choi, C.S. Yong, and J.A. Kim Potent analgesic and anti-inflammatory activities of 1-furan-2-yl-3-pyridin-2-yl-propenone with gastric ulcer sparing effect Biol. Pharm. Bull. 29 2006 361 364 (Pubitemid 43200911)
36. B.C. Park, D. Thapa, Y.S. Lee, M.K. Kwak, E.S. Lee, H.G. Choi, C.S. Yong, and J.A. Kim 1-Furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP Eur. J. Pharmacol. 567 2007 193 197 (Pubitemid 46976892)
37. B.C. Park, S.Y. Park, J.S. Lee, S.A. Mousa, J.T. Kim, M.K. Kwak, K.W. Kang, E.S. Lee, H.G. Choi, C.S. Yong, and J.A. Kim The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling Vascul. Pharmacol. 50 2009 123 131
38. P.E. Harris, P. Ralph, P. Litcofsky, and M.A. Moore Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937 Cancer Res. 45 1985 9 13 (Pubitemid 15196922)
39. Y. Jahng, L.X. Zhao, Y.S. Moon, A. Basnet, E.K. Kim, H.W. Chang, H.K. Ju, T.C. Jeong, and E.S. Lee Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities Bioorg. Med. Chem. Lett. 14 2004 2559 2562 (Pubitemid 38515702)
40. A. Basnet, P. Thapa, R. Karki, Y. Na, Y. Jahng, B.S. Jeong, T.C. Jeong, C.S. Lee, and E.S. Lee 2,4,6-Trisubstituted pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship Bioorg. Med. Chem. 15 2007 4351 4359 (Pubitemid 46777301)
41. N. Kobayashi, A. Ikesue, S. Majumdar, and T.J. Siahaan Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion J. Pharmacol. Exp. Ther. 317 2006 309 316
42. L. Peran, D. Camuesco, M. Comalada, A. Nieto, A. Concha, M.P. Diaz-Ropero, M. Olivares, J. Xaus, A. Zarzuelo, and J. Galvez Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis World J. Gastroenterol. 11 2005 5185 5192 (Pubitemid 41410337)
43. B. Begue, H. Wajant, J.C. Bambou, L. Dubuquoy, D. Siegmund, J.F. Beaulieu, D. Canioni, D. Berrebi, N. Brousse, P. Desreumaux, J. Schmitz, M.J. Lentze, O. Goulet, N. Cerf-Bensussan, and F.M. Ruemmele Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions Gastroenterology 130 2006 1962 1974 (Pubitemid 43816954)
44. M.C. Grimm, S.K. Elsbury, P. Pavli, and W.F. Doe Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa J. Leukoc. Biol. 59 1996 804 812 (Pubitemid 26238475)
45. H.C. Reinecker, E.Y. Loh, D.J. Ringler, A. Mehta, J.L. Rombeau, and R.P. MacDermott Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa Gastroenterology 108 1995 40 50
46. L. Mazzucchelli, C. Hauser, K. Zgraggen, H.E. Wagner, M.W. Hess, J.A. Laissue, and C. Mueller Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease J. Pathol. 178 1996 201 206 (Pubitemid 26057973)
47. M. Sanchez-Hidalgo, A.R. Martin, I. Villegas, and C.A. de la Lastra Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats Eur. J. Pharmacol. 562 2007 247 258 (Pubitemid 46560498)
48. R.I. Scheinman, P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids Science 270 1995 283 286
49. K.H. Shen, J.K. Chang, Y.L. Hsu, and P.L. Kuo Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signalling in human bladder cancer cells Basic Clin. Pharmacol. Toxicol. 101 2007 254 261
50. I.D. Pousa, J. Mate, and J.P. Gisbert Angiogenesis in inflammatory bowel disease Eur. J. Clin. Invest. 38 2008 73 81 (Pubitemid 351143416)
51. S. Danese, M. Sans, D.M. Spencer, I. Beck, F. Donate, M.L. Plunkett, C. de la Motte, R. Redline, D.E. Shaw, A.D. Levine, A.P. Mazar, and C. Fiocchi Angiogenesis blockade as a new therapeutic approach to experimental colitis Gut 56 2007 855 862 (Pubitemid 46854204)
52. Y. Fong, K.J. Tracey, L.L. Moldawer, D.G. Hesse, K.B. Manogue, J.S. Kenney, A.T. Lee, G.C. Kuo, A.C. Allison, and S.F. Lowry Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia J. Exp. Med. 170 1989 1627 1633 (Pubitemid 19284562)
53. S.M. Michalek, H. Kiyono, J.L. Babb, and J.R. McGhee Inheritance of LPS nonresponsiveness and elevated splenic IgA immune responses in mice orally immunized with heterologous erythrocytes J. Immunol. 125 1980 2220 2224 (Pubitemid 10022969)
54. P.B. Sehgal, D.C. Helfgott, U. Santhanam, S.B. Tatter, R.H. Clarick, J. Ghrayeb, and L.T. May Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte- stimulating factor/interleukin 6 gene in virus-infected human fibroblasts J. Exp. Med. 167 1988 1951 1956